Stevenage, United Kingdom
Supply Chain Hub

Stevenage, UK Supply Chain Hub

Positioned for Access, Built for Agility

Located within the growing life sciences cluster of Stevenage, this Supply Chain Hub serves as a strategic facility for clients operating across the United Kingdom and greater Europe. This location is purpose-built to support high-performance logistics operations, including the local dispatch of Cryoport Systems’ temperature-controlled shipping systems.

With proximity to leading biopharma developers, contract manufacturing organizations, and research institutions, the Stevenage facility strengthens our ability to serve the expanding demand for cell therapy, gene therapy, and biopharmaceuticals within the UK, alongside support for other life science applications in animal health and reproductive medicine. It also supports integrated logistics planning and movement across Europe through alignment with our broader global network of facilities.

From our Veri-Clean® process to robust requalification of shipping systems before every use, Cryoport Systems sets the standard for quality and safety in the temperature-controlled supply chain.

Key Capabilities at the Stevenage Supply Chain Hub

Shipping Systems & Logistics Operations

  • Wholly-owned fleet of proprietary Shipping Systems, custom engineered to support the life sciences
  • Local dispatch capabilities for UK-based clinical sites, manufacturing partners, and fertility or veterinary clinics
  • First and last mile delivery support in Stevenage, London, and surrounding area via Cryoshuttle®
  • Fast-turn logistics support for urgent shipments, with after hours and weekend/holiday availability as needed
  • SOPs and quality standards aligned with global Cryoport Systems facilities for consistency

Enabling Consistency Across the UK and EU

Integrated with our full, end-to-end supply chain platform

The Stevenage Supply Chain Hub plays a critical role in bridging UK-based operations with Cryoport Systems’ broader European and global infrastructure. With EU Qualified Person (QP) requirements, this facility enables aligned but distinct logistics coordination, offering flexibility and regulatory preparedness for therapy developers with cross-border movement needs.

As part of our integrated platform, Stevenage supports the synchronized flow of materials from clinical collection through to therapeutic distribution. The facility is positioned to support evolving UK regulatory requirements while offering clients seamless connectivity to the United States, APAC, and the rest of Europe via Cryoport Systems’ global footprint.

Supporting the UK’s Life Sciences Ecosystem

Cryoport Systems’ presence in Stevenage directly supports the region’s growing advanced therapies sector. From its location near the Cell and Gene Therapy Catapult and other key stakeholders, this hub is uniquely situated to contribute to the UK’s leadership in research, development, and commercialization of cell and gene therapies as well as other life sciences applications like animal health and fertility clinics. Whether enabling local delivery of critical starting material, managing clinical trial logistics, or bridging shipments between the UK and EU or US, Stevenage is a vital hub in the global Cryoport Systems supply chain, designed to help clients reduce risk and ensure compliance.